FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC: Form 990, tax year 2011

View the entire original 990 at ProPublica ↗

Organization
FOUNDATION FOR THE NATIONAL INSTITUTE OF HEALTH INC (EIN 52-1986675)
Tax period
2011-01-01 to 2011-12-31
Filed
2012-11-14
IRS object ID
201233199349301408
Schema version
2011v1.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Timestamp2012-11-14T08:24:07-06:00Timestamp
Tax Period End Date2011-12-31TaxPeriodEndDate

Preparer Firm PreparerFirm

FieldValueIRS element (for citing)
EIN560747981EIN

Preparer Firm Business Name PreparerFirmBusinessName

FieldValueIRS element (for citing)
Business Name Line1DIXON HUGHES GOODMAN LLPBusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

FieldValueIRS element (for citing)
Address Line1111 ROCKVILLE PIKE 6TH FLOORAddressLine1
CityROCKVILLECity
StateMDState
ZIP Code20850ZIPCode
FieldValueIRS element (for citing)
Return Type990ReturnType
Tax Period Begin Date2011-01-01TaxPeriodBeginDate

Filer Filer

FieldValueIRS element (for citing)
EIN521986675EIN

Name Name

FieldValueIRS element (for citing)
Business Name Line1FOUNDATION FOR THE NATIONAL INSTITUTESBusinessNameLine1
Business Name Line2OF HEALTH INCBusinessNameLine2
FieldValueIRS element (for citing)
Name ControlFOUNNameControl
Phone3014025311Phone

US Address USAddress

FieldValueIRS element (for citing)
Address Line19650 ROCKVILLE PIKE NO 3411AddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Officer Officer

FieldValueIRS element (for citing)
NameSTEPHANIE JAMES PHDName
TitleINTERIM DIRECTORTitle
Phone3014025311Phone
Date Signed2012-11-08DateSigned
Authorize Third Party1AuthorizeThirdParty

Preparer Preparer

FieldValueIRS element (for citing)
NameROBIN SKINNER CPAName
PTINP00742964PTIN
Phone2404033700Phone
FieldValueIRS element (for citing)
Tax Year2011TaxYear
Build TS2016-02-24 21:20:13ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Name Of Principal Officer PersonSTEPHANIE JAMES PHDNameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

FieldValueIRS element (for citing)
Address Line19650 ROCKVILLE PIKE NO 3411AddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode
FieldValueIRS element (for citing)
Gross Receipts107510023GrossReceipts
Group Return For Affiliates0GroupReturnForAffiliates
Organization501c3XOrganization501c3
Web SiteHTTP://WWW.FNIH.ORGWebSite
Type Of Organization CorporationXTypeOfOrganizationCorporation
Year Formation2001YearFormation
State Legal DomicileMDStateLegalDomicile
Activity Or Mission DescriptionTHE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH (FNIH) WAS ESTABLISHED BY CONGRESS TO SUPPORT THE MISSION OF THE NATIONAL INSTITUTES OF HEALTH (NIH): IMPROVING HEALTH THROUGH SCIENTIFIC DISCOVERY. IN 2011, FNIH ORGANIZED EVENTS SPANNING DOZENS OF FIELDS AND MADE IMPORTANT PROGRESS IN ADVANCING HUMAN HEALTH.ActivityOrMissionDescription
Nbr Voting Members Governing Body26NbrVotingMembersGoverningBody
Nbr Independent Voting Members26NbrIndependentVotingMembers
Total Nbr Employees45TotalNbrEmployees
Total Nbr Volunteers0TotalNbrVolunteers
Total Gross UBI0TotalGrossUBI
Net Unrelated Business Txbl Income0NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year62671114ContributionsGrantsPriorYear
Contributions Grants Current Year59765254ContributionsGrantsCurrentYear
Program Service Revenue Prior Year300796ProgramServiceRevenuePriorYear
Program Service Revenue CY1549687ProgramServiceRevenueCY
Investment Income Prior Year164193InvestmentIncomePriorYear
Investment Income Current Year135308InvestmentIncomeCurrentYear
Other Revenue Prior Year0OtherRevenuePriorYear
Other Revenue Current Year0OtherRevenueCurrentYear
Total Revenue Prior Year63136103TotalRevenuePriorYear
Total Revenue Current Year61450249TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year26565461GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY25483921GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year0BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY0BenefitsPaidToMembersCY
Salaries Etc Prior Year5267527SalariesEtcPriorYear
Salaries Etc Current Year5571047SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year0TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY0TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year141344TotalFundrsngExpCurrentYear
Other Expense Prior Year21785156OtherExpensePriorYear
Other Expenses Current Year19448911OtherExpensesCurrentYear
Total Expenses Prior Year53618144TotalExpensesPriorYear
Total Expenses Current Year50503879TotalExpensesCurrentYear
Revenues Less Expenses Prior Year9517959RevenuesLessExpensesPriorYear
Revenues Less Expenses CY10946370RevenuesLessExpensesCY
Total Assets BOY91290841TotalAssetsBOY
Total Assets EOY98055767TotalAssetsEOY
Total Liabilities BOY17752722TotalLiabilitiesBOY
Total Liabilities EOY13622823TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY73538119NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY84432944NetAssetsOrFundBalancesEOY
Info In Schedule O Part IIIXInfoInScheduleOPartIII
Mission DescriptionSEE SCHEDULE O, STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENTMissionDescription
Significant New Program Services0SignificantNewProgramServices
Significant Change0SignificantChange
Expense42338276Expense
Grants25204871Grants
Revenue1549687Revenue
DescriptionSEE SCHEDULE O, PROGRAM ONE, RESEARCH PARTNERSHIPSDescription

Activity2 Activity2

FieldValueIRS element (for citing)
Expense1486681Expense
Grants243600Grants
DescriptionSEE SCHEDULE O, PROGRAM TWO, FELLOWSHIPS AND TRAINING PROGRAMSDescription

Activity3 Activity3

FieldValueIRS element (for citing)
Expense38516Expense
DescriptionSEE SCHEDULE O, PROGRAM THREE, CAPITAL PROJECTSDescription

Activity Other ActivityOther

FieldValueIRS element (for citing)
Expense3712399Expense
Grants35450Grants
DescriptionSEE SCHEDULE O, MEMORIALS, AWARDS AND EVENTSDescription
FieldValueIRS element (for citing)
Total Of Other Program Service Exp3712399TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt35450TotalOfOtherProgramServiceGrnt
Total Program Service Expense47575872TotalProgramServiceExpense
Described In501 C31DescribedIn501C3
Schedule B Required1ScheduleBRequired
Political Activities0PoliticalActivities
Lobbying Activities0LobbyingActivities
Subject To Proxy Tax0SubjectToProxyTax
Donor Advised Funds1DonorAdvisedFunds
Conservation Easements0ConservationEasements
Collections Of Art0CollectionsOfArt
Credit Counseling1CreditCounseling
Term Or Permanent Endowments1TermOrPermanentEndowments
Report Land Bldg Equip1ReportLandBldgEquip
Report Invest Oth Securities1ReportInvestOthSecurities
Report Prog Rel Invest0ReportProgRelInvest
Report Other Assets0ReportOtherAssets
Report Other Liabilities0ReportOtherLiabilities
Report Fin48 Footnote1ReportFin48Footnote
Independent Audit Financial Stmt1IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt0ConsolidatedAuditFinancialStmt
School0School
Foreign Office0ForeignOffice
Foreign Activities0ForeignActivities
More Than5000 K To Organizations1MoreThan5000KToOrganizations
More Than5000 K To Individuals0MoreThan5000KToIndividuals
Professional Fundraising0ProfessionalFundraising
Fundraising Activities0FundraisingActivities
Gaming0Gaming
Hospital0Hospital
Grants To Organizations1GrantsToOrganizations
Grants To Individuals1GrantsToIndividuals
Schedule J Required1ScheduleJRequired
Tax Exempt Bonds0TaxExemptBonds
Excess Benefit Transaction0ExcessBenefitTransaction
Prior Excess Benefit Transaction0PriorExcessBenefitTransaction
Loan To Officer Or DQP0LoanToOfficerOrDQP
Grant To Related Person0GrantToRelatedPerson
Bsnss Rltnshp With Organization0BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member0BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp0OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions0DeductibleNonCashContributions
Deductible Contributions Of Art0DeductibleContributionsOfArt
Terminated0Terminated
Partial Liquidation0PartialLiquidation
Disregarded Entity0DisregardedEntity
Related Entity0RelatedEntity
Related Org Controlled Entity0RelatedOrgControlledEntity
Transaction Related Entity0TransactionRelatedEntity
Transfers To Exempt Non Chrtbl Org0TransfersToExemptNonChrtblOrg
Activities Conducted Partnership0ActivitiesConductedPartnership
Schedule O Required1ScheduleORequired
Number Forms Transmitted With109641NumberFormsTransmittedWith1096
Number W2 G Included0NumberW2GIncluded
Compliance With Backup Witholding1ComplianceWithBackupWitholding
Number Of Employees45NumberOfEmployees
Employment Tax Returns Filed1EmploymentTaxReturnsFiled
Unrelated Business Income0UnrelatedBusinessIncome
Foreign Financial Account0ForeignFinancialAccount
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTrans
Taxable Party Notification0TaxablePartyNotification
Non Deductible Contributions0NonDeductibleContributions
Quid Pro Quo Contributions0QuidProQuoContributions
Form8282 Property Disposed Of0Form8282PropertyDisposedOf
Funds To Pay Premiums0FundsToPayPremiums
Premiums Paid0PremiumsPaid
Excess Business Holdings0ExcessBusinessHoldings
Taxable Distributions0TaxableDistributions
Distribution To Donor0DistributionToDonor
Indoor Tanning Services0IndoorTanningServices
Info In Schedule O Part VIXInfoInScheduleOPartVI
Nbr Voting Governing Body Members26NbrVotingGoverningBodyMembers
Number Independent Voting Members26NumberIndependentVotingMembers
Family Or Business Relationship0FamilyOrBusinessRelationship
Delegation Of Management Duties0DelegationOfManagementDuties
Changes To Organizing Docs1ChangesToOrganizingDocs
Material Diversion Or Misuse0MaterialDiversionOrMisuse
Members Or Stockholders0MembersOrStockholders
Election Of Board Members0ElectionOfBoardMembers
Decisions Subject To Approval0DecisionsSubjectToApproval
Minutes Of Governing Body1MinutesOfGoverningBody
Minutes Of Committees1MinutesOfCommittees
Officer Mailing Address0OfficerMailingAddress
Local Chapters0LocalChapters
Form990 Provided To Governing Body1Form990ProvidedToGoverningBody
Conflict Of Interest Policy1ConflictOfInterestPolicy
Annual Disclosure Covered Persons1AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement1RegularMonitoringEnforcement
Whistleblower Policy1WhistleblowerPolicy
Document Retention Policy1DocumentRetentionPolicy
Compensation Process CEO1CompensationProcessCEO
Compensation Process Other1CompensationProcessOther
Investment In Joint Venture0InvestmentInJointVenture
States Where Copy Of Return Is FiledMDStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledVAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNYStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledALStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledAKStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledAZStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledARStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCOStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledCTStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledFLStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledGAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledHIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledILStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledKSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledKYStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMEStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMSStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledMNStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNHStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNJStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNMStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledNDStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledOHStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledOKStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledORStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledPAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledRIStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledSCStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledTNStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledUTStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWAStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWVStatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is FiledWIStatesWhereCopyOfReturnIsFiled
Own WebsiteXOwnWebsite
Upon RequestXUponRequest

The Books Are In Care Of TheBooksAreInCareOf

Name Business NameBusiness

FieldValueIRS element (for citing)
Business Name Line1JULIE TUNEBusinessNameLine1
FieldValueIRS element (for citing)
Telephone Number3014025311TelephoneNumber

Address US AddressUS

FieldValueIRS element (for citing)
Address Line19650 ROCKVILLE PIKEAddressLine1
CityBETHESDACity
StateMDState
ZIP Code20814ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (39 entries)

TitleTitleAverage Hours Per WeekAverageHoursPerWeekIndividual Trustee Or DirectorIndividualTrusteeOrDirectorReportable Comp From OrganizationReportableCompFromOrganizationReportable Comp From Related OrgsReportableCompFromRelatedOrgsOther CompensationOtherCompensationOfficerOfficerKey EmployeeKeyEmployeeHighest Compensated EmployeeHighestCompensatedEmployee
CHARLES A SANDERS MD
CHAIRMAN2.00X000
PAUL M MONTRONE PHD
TREASURER1.50X000
JOHN EDWARD PORTER
VICE CHAIRMAN1.50X000
MRS WILLIAM MCCORMICK BLAIR
SECRETARY1.00X000
KATHY BLOOMGARDEN PHD
BOARD MEMBER0.50X000
MRS WILLIAM N CAFRITZ
BOARD MEMBER0.50X000
ANN LURIE
BOARD MEMBER0.50X000
JOSEPH M FECZKO MD
BOARD MEMBER0.50X000
MILES GILBURNE
BOARD MEMBER0.50X000
CAROLINE A KOVAC PHD
BOARD MEMBER0.50X000
SHERRY LANSING
BOARD MEMBER0.50X000
MARTIN MURPHY JR PHD
BOARD MEMBER0.50X000
STEVEN M PAUL MD
BOARD MEMBER0.50X000
PHILIP A PIZZO MD
BOARD MEMBER0.50X000
JILLIAN SACKLER DBE
BOARD MEMBER0.50X000
LILY SAFRA
BOARD MEMBER0.50X000
KURT L SCHMOKE JD
BOARD MEMBER0.50X000
ELLEN V SIGAL PHD
BOARD MEMBER0.50X000
SOLOMON H SNYDER MD
BOARD MEMBER0.50X000
STEPHEN SPIELBERGMDPHD
BOARD MEMBER0.50X000
SAMUEL O THIER MD
BOARD MEMBER0.50X000
PATRICK C WALSH MD
BOARD MEMBER0.50X000
ANNE WOJCICKI
BOARD MEMBER0.50X000
PAUL BERG PHD
DIRECTOR EMERITUS0.50X000
LUTHER W BRADY MD
HONORARY DIRECTOR0.50X000
FREDA LEWIS-HALL MD
BOARD MEMBER0.50X000
SCOTT CAMPBELL
EXECUTIVE DIRECTOR AND CEO40.00222288026825X
DAVID WHOLLEY
DIR BIOMARKERS CONSORTIUM40.00258423035802X
STEPHANIE JAMES
DIR OF SCIENCE AND GCGH40.00261148026115X
ANDREA BARUCHIN
DIR NIH RELATIONS40.00182510022847X
RICHARD SCARFO
DIR MKTG AND STRATEGIC ALL40.00165114026471X
JULIE TUNE
CHIEF FINANCIAL OFFICER40.00168143026774X
ANN ASHBY
DEPUTY EXECUTIVE DIRECTOR40.00193186029279X
JULIE WOLF-RODDA
DIR PSHIP DEVELOPMENT40.00171808027141X
MICHAEL GOTTLIEB
ASSOC DIR OF SCIENCE40.00214468021447X
JUDITH SIUCIAK
SCIENTIFIC PROGRAM MANAGER40.00144870024447X
GAIL LEVINE
SCIENTIFIC PROGRAM MANAGER40.00136705023631X
SONIA PEARSON-WHITE
SCIENTIFIC PROGRAM MANAGER40.00117947016391X
MARIA VASSILEVA
SCIENTIFIC PROGRAM MANAGER40.00112198021180X
FieldValueIRS element (for citing)
Total Reportable Comp From Org2348808TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs0TotalReportableCompFrmRltdOrgs
Total Other Compensation328350TotalOtherCompensation
Number Individuals GT100 K13NumberIndividualsGT100K
Formers Listed0FormersListed
Total Comp GT150 K1TotalCompGT150K
Compensation From Other Sources0CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1CityAddressOfContractor/AddressUS/CityStateAddressOfContractor/AddressUS/StateZIP CodeAddressOfContractor/AddressUS/ZIPCodeDescription Of ServicesDescriptionOfServicesCompensationCompensation
OGILVY PUBLIC RELATIONS WORLDWIDE
PO BOX 7242PHILADELPHIAPA19170PROFESSIONAL SERVICES936075
EPHIR INC
PO BOX 253SWAMPSCOTTMA01907RESARCH LAB RELEASE MANAGEMENT676630
DIGITAL AURORA
PO BOX 648 174 SARGENT LANEMANCHESTERVT05254CONSULTING590395
SAS INSTITUTE INC
PO BOX 406922ATLANTAGA30384INFORMATION TECHNOLOGY500000
GAYLORD NATIONAL LLC
WATERFRONT STREETOXON HILLMD20745CONFERENCES AND MEETINGS424978
FieldValueIRS element (for citing)
Number Of Contractors GT100 K5NumberOfContractorsGT100K
Government Grants486000GovernmentGrants
All Other Contributions59279254AllOtherContributions
Total Contributions59765254TotalContributions

Program Service Revenue ProgramServiceRevenue (2 entries)

DescriptionDescriptionBusiness CodeBusinessCodeTotal Revenue ColumnTotalRevenueColumnRelated Or Exempt Function IncomeRelatedOrExemptFunctionIncome
REGISTRATION AND EXHIB54170012128231212823
ADMINISTRATIVE FEES561000336864336864
FieldValueIRS element (for citing)
Total Program Service Revenue1549687TotalProgramServiceRevenue

Investment Income InvestmentIncome

FieldValueIRS element (for citing)
Total Revenue Column134140TotalRevenueColumn
Exclusion$134,140ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

FieldValueIRS element (for citing)
Securities46060942Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

FieldValueIRS element (for citing)
Securities46059774Securities

Gain Or Loss GainOrLoss

FieldValueIRS element (for citing)
Securities1168Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

FieldValueIRS element (for citing)
Total Revenue Column1168TotalRevenueColumn
Exclusion$1,168ExclusionAmount

Total Revenue TotalRevenue

FieldValueIRS element (for citing)
Total Revenue Column61450249TotalRevenueColumn
Related Or Exempt Function Income1549687RelatedOrExemptFunctionIncome
Unrelated Business Revenue0UnrelatedBusinessRevenue
Exclusion$135,308ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

FieldValueIRS element (for citing)
Total15513099Total
Program Services15513099ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

FieldValueIRS element (for citing)
Total288050Total
Program Services288050ProgramServices

Foreign Grants ForeignGrants

FieldValueIRS element (for citing)
Total9682772Total
Program Services9682772ProgramServices

Comp Current Officers Directors CompCurrentOfficersDirectors

FieldValueIRS element (for citing)
Total2677158Total
Program Services1705328ProgramServices
Management And General959558ManagementAndGeneral
Fundraising12272Fundraising

Other Salaries And Wages OtherSalariesAndWages

FieldValueIRS element (for citing)
Total1896493Total
Program Services1216294ProgramServices
Management And General596229ManagementAndGeneral
Fundraising83970Fundraising

Other Employee Benefits OtherEmployeeBenefits

FieldValueIRS element (for citing)
Total685469Total
Program Services432264ProgramServices
Management And General230252ManagementAndGeneral
Fundraising22953Fundraising

Payroll Taxes PayrollTaxes

FieldValueIRS element (for citing)
Total311927Total
Program Services145086ProgramServices
Management And General166841ManagementAndGeneral

Fees For Services Legal FeesForServicesLegal

FieldValueIRS element (for citing)
Total468002Total
Program Services461245ProgramServices
Management And General6757ManagementAndGeneral

Fees For Services Accounting FeesForServicesAccounting

FieldValueIRS element (for citing)
Total57375Total
Management And General57375ManagementAndGeneral

Advertising Advertising

FieldValueIRS element (for citing)
Total28040Total
Program Services13960ProgramServices
Management And General14080ManagementAndGeneral

Office Expenses OfficeExpenses

FieldValueIRS element (for citing)
Total33251Total
Program Services14327ProgramServices
Management And General18710ManagementAndGeneral
Fundraising214Fundraising

Information Technology InformationTechnology

FieldValueIRS element (for citing)
Total1193931Total
Program Services1110552ProgramServices
Management And General83379ManagementAndGeneral

Occupancy Occupancy

FieldValueIRS element (for citing)
Total361991Total
Program Services159541ProgramServices
Management And General202450ManagementAndGeneral

Travel Travel

FieldValueIRS element (for citing)
Total2464332Total
Program Services2356907ProgramServices
Management And General103013ManagementAndGeneral
Fundraising4412Fundraising

Depreciation Depletion DepreciationDepletion

FieldValueIRS element (for citing)
Total51982Total
Management And General51982ManagementAndGeneral

Insurance Insurance

FieldValueIRS element (for citing)
Total170674Total
Program Services125284ProgramServices
Management And General45390ManagementAndGeneral

Other Expenses OtherExpenses (4 entries)

DescriptionDescriptionTotalTotalProgram ServicesProgramServicesManagement And GeneralManagementAndGeneralFundraisingFundraising
PROGRAM CONTRACTS1028912110289121
CONSULTANTS3969517387176697751
PRINTING AND PHOTOCOPYI10663669880282858471
SERVICE CHARGES1034064419659210

All Other Expenses AllOtherExpenses

FieldValueIRS element (for citing)
Total150653Total
Program Services76200ProgramServices
Management And General65401ManagementAndGeneral
Fundraising9052Fundraising

Total Functional Expenses TotalFunctionalExpenses

FieldValueIRS element (for citing)
Total50503879Total
Program Services47575872ProgramServices
Management And General2786663ManagementAndGeneral
Fundraising141344Fundraising

Savings And Temp Cash Investments SavingsAndTempCashInvestments

FieldValueIRS element (for citing)
BOY40446083BOY
EOY55108789EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

FieldValueIRS element (for citing)
BOY22057687BOY
EOY18080849EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

FieldValueIRS element (for citing)
BOY83002BOY
EOY102130EOY
FieldValueIRS element (for citing)
Land Buildings Equipment Basis589354LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec483657LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

FieldValueIRS element (for citing)
BOY98438BOY
EOY105697EOY

Investments Other Securities InvestmentsOtherSecurities

FieldValueIRS element (for citing)
BOY28605631BOY
EOY24658302EOY

Total Assets TotalAssets

FieldValueIRS element (for citing)
BOY91290841BOY
EOY98055767EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

FieldValueIRS element (for citing)
BOY1252432BOY
EOY2561263EOY

Deferred Revenue DeferredRevenue

FieldValueIRS element (for citing)
BOY14755033BOY
EOY7862751EOY

Escrow Account Liability EscrowAccountLiability

FieldValueIRS element (for citing)
BOY1745257BOY
EOY3198809EOY

Total Liabilities TotalLiabilities

FieldValueIRS element (for citing)
BOY17752722BOY
EOY13622823EOY
FieldValueIRS element (for citing)
Follow SFAS117XFollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

FieldValueIRS element (for citing)
BOY9103221BOY
EOY10078788EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY61126724BOY
EOY71045848EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

FieldValueIRS element (for citing)
BOY3308174BOY
EOY3308308EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY73538119BOY
EOY84432944EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

FieldValueIRS element (for citing)
BOY91290841BOY
EOY98055767EOY
FieldValueIRS element (for citing)
Info In Schedule O Part XIXInfoInScheduleOPartXI
Reconcilation Revenue Expenses10946370ReconcilationRevenueExpenses
Reconcilation Other Changes-51545ReconcilationOtherChanges
Info In Schedule O Part XIIXInfoInScheduleOPartXII
Method Of Accounting AccrualXMethodOfAccountingAccrual
Accountant Compile Or Review0AccountantCompileOrReview
FS Audited1FSAudited
Audit Committee1AuditCommittee
Financial Statement SeparateXFinancialStatementSeparate
Federal Grant Audit Required0FederalGrantAuditRequired

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Publicly Supported Org170b1 AviXPubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years56897459CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years81264504CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years71174551CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year63125631CurrentTaxYearMinus1Year
Current Tax Year59279254CurrentTaxYear
Total331741399Total

Value Srvc Fclts Furnished By Govt ValueSrvcFcltsFurnishedByGovt

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years587451CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years584653CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years503112CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year500000CurrentTaxYearMinus1Year
Current Tax Year486000CurrentTaxYear
Total2661216Total

Total170 Total170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years57484910CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years81849157CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years71677663CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year63625631CurrentTaxYearMinus1Year
Current Tax Year59765254CurrentTaxYear
Total334402615Total
FieldValueIRS element (for citing)
Amounts Subst Contributors Total170018519AmountsSubstContributorsTotal
Public Support Total170164384096PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years8171307CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years3698901CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years806143CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year173991CurrentTaxYearMinus1Year
Current Tax Year134140CurrentTaxYear
Total12984482Total
FieldValueIRS element (for citing)
Total Support347387097TotalSupport
Gross Receipts From Admissions Etc3058082GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage1700.47320PublicSupportPertcentage170
Public Support Pertcent Prior Year0.64610PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170XThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

FieldValueIRS element (for citing)
Contributor NumberRESTRICTEDContributorNumber

Contributor Name Business ContributorNameBusiness

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor Address US ContributorAddressUS

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Aggregate ContributionsRESTRICTEDAggregateContributions

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Number DA Fs Held2NumberDAFsHeld
Donor Advised Contributions480186DonorAdvisedContributions
Grants Paid From Donor Funds1013301GrantsPaidFromDonorFunds
Aggregate DAF Value8116661AggregateDAFValue
Disclosed Orgs Legal Control1DisclosedOrgsLegalControl
Disclosed For Charitable Purposes1DisclosedForCharitablePurposes
Agent Trustee Etc0AgentTrusteeEtc
Included On FS1IncludedOnFS

Current Year CurrentYear

FieldValueIRS element (for citing)
Beginning Of Year Balance3690564BeginningOfYearBalance
Contributions3214Contributions
Investment Earnings Or Losses-91InvestmentEarningsOrLosses
Administrative Expenses63053AdministrativeExpenses
End Of Year Balance3630634EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

FieldValueIRS element (for citing)
Beginning Of Year Balance3736712BeginningOfYearBalance
Contributions9744Contributions
Investment Earnings Or Losses23343InvestmentEarningsOrLosses
Administrative Expenses79235AdministrativeExpenses
End Of Year Balance3690564EndOfYearBalance

Current Year Minus2 Years CurrentYearMinus2Years

FieldValueIRS element (for citing)
Beginning Of Year Balance3791493BeginningOfYearBalance
Contributions20898Contributions
Investment Earnings Or Losses48619InvestmentEarningsOrLosses
Administrative Expenses124298AdministrativeExpenses
End Of Year Balance3736712EndOfYearBalance

Current Year Minus3 Years CurrentYearMinus3Years

FieldValueIRS element (for citing)
Beginning Of Year Balance3777493BeginningOfYearBalance
Contributions10445Contributions
Investment Earnings Or Losses104761InvestmentEarningsOrLosses
Administrative Expenses101206AdministrativeExpenses
End Of Year Balance3791493EndOfYearBalance
FieldValueIRS element (for citing)
Permanent Endowment EOY Balance0.91000PermanentEndowmentEOYBalance
Term Endowment EOY Balance0.09000TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs0EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs0EndowmentsHeldByRelatedOrgs

Equipment Equipment

FieldValueIRS element (for citing)
Other Cost Or Other Basis441663OtherCostOrOtherBasis
Depreciation359866Depreciation
Book Value81797BookValue

Other Land Buildings OtherLandBuildings

FieldValueIRS element (for citing)
Other Cost Or Other Basis147691OtherCostOrOtherBasis
Depreciation123791Depreciation
Book Value23900BookValue
FieldValueIRS element (for citing)
Total Of Book Value Land Buildings105697TotalOfBookValueLandBuildings

Other Securities OtherSecurities (8 entries)

DescriptionDescriptionBook ValueBookValueMethod Of ValuationMethodOfValuation
DISCOUNT NOTES10491440F
BOND MUTUAL FUNDS398377F
EQUITY MUTUAL FUNDS162022F
CORPORATE BONDS93114F
GOVERNMENT BONDS12996930F
STOCKS469857F
REIT18461F
EXCHANGE TRADED FUNDS28101F
FieldValueIRS element (for citing)
Total Of Book Value Securities24658302TotalOfBookValueSecurities
Total Revenue61450249TotalRevenue
Total Expenses50503879TotalExpenses
Excess Or Deficit For Year10946370ExcessOrDeficitForYear
Net Unrealized GL On Investments-51545NetUnrealizedGLOnInvestments
Total Adjustments-51545TotalAdjustments
Excess Or Deficit Per FS10894825ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt63480862TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments-51545NetUnrealizedGainsInvestments
Donated Srvc And Use Of Facilities44892DonatedSrvcAndUseOfFacilities
Other Revenues2037266OtherRevenues
Revenue Not Rptd F9902030613RevenueNotRptdF990
Revenue Subtotal61450249RevenueSubtotal
Revenue Not Rptd On Fin Stmt0RevenueNotRptdOnFinStmt
Total Revenue Per Form99061450249TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt52586037TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities44892DonatedServicesUseOfFacilities
Other Expenses Included2037266OtherExpensesIncluded
Expenses Not Rptd F9902082158ExpensesNotRptdF990
Expenses Subtotal50503879ExpensesSubtotal
Expenses Not Rptd On Fin Stmt0ExpensesNotRptdOnFinStmt
Total Expenses Per Form99050503879TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (5 entries)

Return ReferenceReturnReferenceExplanationExplanationIdentifierIdentifier
PART IV, LINE 2B:AS OF 12/31/2011, THE FNIH HELD $3,198,809 IN AGENCY FUNDS FOR FUTURE DISTRIBUTION TO THE NATIONAL INSTITUTES OF HEALTH (NIH). THESE FUNDS ARE DESIGNATED BY THE FUNDER(S) FOR SPECIFIC PROJECTS AT THE NIH, AND WILL BE DISBURSED AS NEEDED.
PART V, LINE 4:THE FOUNDATION'S ENDOWMENTS CONSIST OF INDIVIDUAL DONOR-RESTRICTED ENDOWMENT FUNDS ESTABLISHED FOR A VARIETY OF PURPOSES. (E.G. VARIETY OF RESEARCH AND EDUCATIONAL INITIATIVES AT THE FOUNDATION FOR THE NIH). NET ASSETS ASSOCIATED WITH ENDOWMENT FUNDS ARE CLASSIFIED AND REPORTED BASED ON THE EXISTENCE OR ABSENCE OF DONOR-IMPOSED RESTRICTIONS.DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS:
PART X:THE FOUNDATION IS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE; ACCORDINGLY, THE ACCOMPANYING FINANCIAL STATEMENTS DO NOT REFLECT A PROVISION OR LIABILITY FOR FEDERAL AND STATE INCOME TAXES. THE FOUNDATION HAS DETERMINED THAT IT DOES NOT HAVE ANY MATERIAL UNRECOGNIZED TAX BENEFITS OR OBLIGATIONS AS OF DECEMBER 31, 2011 AND 2010. FISCAL YEARS ENDING ON OR AFTER DECEMBER 31, 2008 REMAIN SUBJECT TO EXAMINATION BY FEDERAL AND STATE TAX AUTHORIES.DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48:
IN KIND CONTRIBUTIONSPART XII, LINE 2D - OTHER ADJUSTMENTS:
IN KIND CONTRIBUTIONSPART XIII, LINE 2D - OTHER ADJUSTMENTS:

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records Maintained1GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)

RegionRegionType Of Activities ConductedTypeOfActivitiesConductedTotal ExpendituresTotalExpenditures
EAST AISA & THE PACIFICGRANTMAKING4079819
EUROPEGRANTMAKING4391797
SUB-SAHARAN AFRICAGRANTMAKING277573
SOUTH ASIAGRANTMAKING933583
FieldValueIRS element (for citing)
Subtotal Number Of Offices0SubtotalNumberOfOffices
Subtotal Number Of Employees0SubtotalNumberOfEmployees
Cont Number Of Offices0ContNumberOfOffices
Cont Number Of Employees0ContNumberOfEmployees
Total Number Of Offices0TotalNumberOfOffices
Total Number Of Employees0TotalNumberOfEmployees
Subtotal Amount Spent9682772SubtotalAmountSpent
Cont Amount Spent0ContAmountSpent
Total Amount Spent9682772TotalAmountSpent
No Recipient Over5 KXNoRecipientOver5K

Grants To Orgs Outside US GrantsToOrgsOutsideUS (14 entries)

RegionRegionPurpose Of GrantPurposeOfGrantAmount Of Cash GrantAmountOfCashGrantManner Of Cash DisbursementMannerOfCashDisbursement
EUROPEDEVELOP A GENETIC STRATEGY TO DEPLETE OR INCAPACITATE INSECTS2000000WIRE TRANSFER
EAST ASIA AND THE PACIFICMODIFYING MOSQUITO POPULATION AGE STRUCTURE TO ELIMINATE DENGUE TRANSMISSION733295WIRE TRANSFER
EUROPEIMMUNE CORRELATES115152WIRE TRANSFER
EUROPENON-HUMAN PRIMATE CORE26884WIRE TRANSFER
SOUTH ASIAMALNUTRITION AND ENTERIC DISEASES NETWORK518070WIRE TRANSFER
SOUTH ASIAMALNUTRITION AND ENTERIC DISEASES NETWORK415513WIRE TRANSFER
EUROPEIMMUNOGENICITY STUDY(CECI)13333WIRE TRANSFER
EUROPEDISTRIBUTED PARTNER IN METHODS/OMOP33602WIRE TRANSFER
EUROPECREATE NEW VACCINES1350000WIRE TRANSFER
EUROPEIDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS412095WIRE TRANSFER
SUB-SAHARAN AFRICAIDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS277573WIRE TRANSFER
EAST ASIA AND THE PACIFICMODIFYING MOSQUITO POPULATION AGE STRUCTURE TO ELIMINATE DENGUE TRANSMISSION3346524WIRE TRANSFER
EUROPEIDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS372944WIRE TRANSFER
EUROPEDETECTION OF LONG TERM ADVERSE DRUG REACTIONS IN ELECTRONIC HEALTH CARE DATA67787WIRE TRANSFER
FieldValueIRS element (for citing)
Total Number Of501c3 Orgs2TotalNumberOf501c3Orgs
Total Number Of Other Orgs12TotalNumberOfOtherOrgs
Transfer To Foreign Corp0TransferToForeignCorp
Interest In Foreign Trust0InterestInForeignTrust
Own Foreign Corp0OwnForeignCorp
Passive Foreign Invest Co0PassiveForeignInvestCo
Foreign Partnership0ForeignPartnership
Boycott Countries0BoycottCountries

Form990 Schedule F Part V Form990ScheduleFPartV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.:Identifier
ExplanationSCHEDULE F, PART I, LINE 2: PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS SOME DEVELOPING COUNTRY INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS.Explanation

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Records Maintained1RecordsMaintained

Recipient Table RecipientTable (38 entries)

Address Line1AddressUS/AddressLine1CityAddressUS/CityStateAddressUS/StateZIP CodeAddressUS/ZIPCodeEIN Of RecipientEINOfRecipientIRC SectionIRCSectionAmount Of Cash GrantAmountOfCashGrantPurpose Of GrantPurposeOfGrantAddress Line2AddressUS/AddressLine2
BETH ISRAEL DEACONESS MEDICAL CENTER
330 BROOKLINE AVENUEBOSTONMA02215042103881501(C)(3)271769NON HUMAN PRIMATE NEW ASSAY
CALIFORNIA PACIFIC MEDICAL CENTER
475 BRANNAN STREET SUITE 220SAN FRANCISCOCA94107950562680501(C)(3)31500SARCOPENIA
CHICAGO ASSOCIATION FOR RESEARCH AND EDUCATION IN SCIENCE (CARES)
BUILDING ONE ROOM C347 5000 SOUTHHINESIL60141363334177501(C)(3)119246DISTRIBUTED RESEARCH PARTNER COLLABORATION WITH THE OMOP5TH AVENUE
COLUMBIA UNIVERSITY
722 WEST 168TH ST 4TH FLOORNEW YORKNY10032135598093501(C)(3)91566SARCOPENIA
DUKE UNIVERSITY
2200 WEST MAIN STREET SUITE 820DURHAMNC27705560532129501(C)(3)831108PROFICIENCY TESTING CENTRAL/CECIERWIN SQUARE PLAZA
EMORY UNIVERSITY
1599 CLIFTON ROAD NE 4TH FLOORATLANTAGA30322580566256501(C)(3)43713IMMUNOLOGICAL STRATEGIES FOR CURING CHRONIC HEPATITIS VIRUS INFECTIONS
FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVE NSEATTLEWA98109237156071501(C)(3)277821CLADE SPECIFIC T CELL RESPONSES
HENRY JACKSON FOUNDATION (USMHRP )
1401 ROCKVILLE PIKE SUITE 600ROCKVILLEMD20852521317896501(C)(3)447090PROFICIENCY TESTING/MAL-ED
HUMANA INC
500 WEST MAIN STREETLOUISVILLEKY20202611383567240879OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
JOHNS HOPKINS UNIVERSITY
615 N WOLFE ST W1100BALTIMOREMD212051505951101215607MAL-ED
PARTNERS HEALTHCARE SYSTEM INC
ONE CONSTITUTION CENTERCHARLESTOWNMA02129043230035501(C)(3)231556OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
SDI HEALTH LLC
220 WEST GERMANTOWN PIKEPLYMOUTH MEETINGPA19462262863550217225OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
SLIPPERY ROCK UNIVERSITY FOUNDATION
100 OLD MAIN 1 MORROW WAYSLIPPERY ROCKPA16057251513539501(C)(3)6500"ENHANCE PHYSICAL ACTIVITY, GOOD NUTRITION, FITNESS AND HEALTHY LIFESTYLES IN CHILDREN AND YOUTH DISABILITIES."
TRUSTEES OF COLUMBIA UNIVERSITY OF THE CITY OF NEW YORK
630 WEST 168TH STREETNEW YORKNY10032135598093501(C)(3)1750000MOLECULAR APPROACHES TO ALTER OLFACTORY-DRIVEN BEHAVIORS OF INSECT DISEASE VECTORS
TRUSTEES OF INDIANA UNIVERSITY
PO BOX 66057INDIANAPOLISIN46266356001673380486OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
UNIVERSITY OF CALIFORNIA IRVINE
300 UNIVERSITY TOWERIRVINECA926979525401172000000GENETIC STRATEGIES FOR CONTROL OF DENGUE VIRUS TRANSMISSION
UNIVERSITY OF MARYLAND BALTIMORE
PO BOX 41428MARYLANDMD2120331167867931500SARCOPENIA
UNIVERSITY OF VIRGINIA
PO BOX 400195CHARLOTTESVILLEVA22904546001796GOVERNMENT UNIT1572625MAL-ED
VACCINE AND GENE THERAPY INSTITUTE FLORIDA
11350 SW VILLAGE PARKWAY THIRDPORT ST LUCIEFL34987364631835171(C)(1)731440VIMC/INNATE AND MUCOSAL IMMUNITY DISCOVERY TEAMFLOOR
VANDERBILT UNIVERSITY
2301 VANDERLBILT PLACENASHVILLETN37235620476822501(C)(3)1000000DISRUPTION OF MALARIA TRANSMISSION/VECTOR
IAVI
110 WILLIAM STREET FLOOR 27NEW YORKNY10038133870223501(C)(3)487481CTV SCIENTIFIC CORE LABORATORIES
NORTHEASTERN UNIVERSITY
360 HUNTINGTON AVE 960 RPBOSTONMA02115041679980501(C)(3)20000SARCOPENIA
TRUSTEES OF BOSTON UNIVERSITY
85 E NEWTON ST M-921BOSTONMA02118042103547501(C)(3)660801ILLUMINATING THE CELLULAR TROPISM OF MEASLES VACCINE VIRUSES IN MACAQUES
AUBURN UNIVERSITY
310 SAMFORD HALLAUBURNAL36849636000724501(C)(3)212850DEVELOPING A STRUCTURED PROCESS FOR MEASURING AND INTERPRETING HEALTH OUTCOMES OF INTEREST IN THE OMOP COMMON DATA MODEL
CARDIOLOGY ASSOCIATES
405 SOUTHWEST DRIVE PMBJONESBOROAR72401200213310501(C)(3)27250HEART TRUTH
COLORADO STATE UNIVERSITY
601 HOWES STREETFORT COLLINSCO80523170(C)(1)466830MOLECULAR MOSQUITOCIDES: DEVELOPMENT OF AN INNOVATICE AND ROBUST, PLATFORM-BASED APPROACH FOR SUSTAINABLE INSECTICIDAL CONTROL OF ANOPHELINE MOSQUITOES
COMMUNITY HEALTH
225 MEMORIAL DRIVEBERLINWI54923731639346501(C)(3)25100HEART TRUTH
COVENANT HEALTH
1921 TOPSIDE ROAD SUITE 100LOUISVILLETN37777621646734501(C)(3)29700KNOW YOUR SIX, CHICK
MASSACHUSETTS GENERAL HOSPITAL
55 FRUIT STREETBOSTONMA02114041564655501(C)(3)131800OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP
NIH-FIC
16 CENTER DRIVEBETHESDAMD20892520858115170(C)(1)355353MAL-ED
SWAT EMPOWERMENT
PO BOX 796SPARTAGA31087651178033501(C)(3)30000HEART TRUTH
THE OHIO STATE UNIVERSITY
1960 KENNY RDCOLOMBUSOH43210316025986170(C)(1)466522HIGH THROUGHPUT DISCOVERY OF CHEMICALS THAT INDUCE 'KIDNEY' FAILURE IN THE MALARIAL VECTOR ANOPHELES GAMBIAE
THE HOPE HEART INSTITUTE
1380 112TH AVE NEBELLEVUEWA98004911138000501(C)(3)29555HEART TRUTH
UNIVERSITY OF FLORIDA BOARD OF TRUSTEES
PO BOX 115500GAINESVILLEFL23611596002052170(C)(1)463018VOLTAGE-SENSITIVE POTASSIUM CHANNEL AS NEW TARGET FOR MOSQUITOCIDES
UCLA
405 HILGARD AVENUELOS ANGELESCA90095GOVERNMENT UNIT62303HIGH PERFORMANCE STATISTICAL INFERENCE FOR OMOP
VESTARON CORPORATION
4717 CAMPUS DRIVE SUITE 1200KALAMAZOOMI49008203831543498881DEVELOPMENT OF SYNTHETIC CHEMICAL MIMICS OF SELECTIVELY INSECTICIDAL NATURAL PEPTIDES
WHEATON FRANCISCAN HEALTHCARE
400 W RIVER WOOD PARKWAYGLENDALEWI53212391636804501(C)(3)21515HEART TRUTH
YMCA MIDDLE RIO
210 TRUMAN ST NE SUITE AALBUQUERQUENM49008850107101501(C)(3)30000WOMEN'S HEALTH EQUITY
FieldValueIRS element (for citing)
Total Nbr Of501 C3 And Govt Grants27TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations15TotalNbrOfOtherOrganizations

Form990 Schedule I Part III Form990ScheduleIPartIII

FieldValueIRS element (for citing)
Type Of GrantAWARDSTypeOfGrant
Number Of Recipients42NumberOfRecipients
Amount Of Cash Grant265750AmountOfCashGrant

Form990 Schedule I Part IV Form990ScheduleIPartIV

FieldValueIRS element (for citing)
IdentifierPROCEDURE FOR MONITORING GRANTS IN THE U.S.:Identifier
Return ReferencePART I, LINE 2:ReturnReference
ExplanationSCHEDULE I, PART I, LINE 2: PROGRAM AND GRANTS MANAGEMENT STAFF INVEST CONSIDERABLE EFFORT IN PROVIDING SCIENTIFIC, ADMINISTRATIVE, AND FISCAL OVERSIGHT FOR FNIH GRANTS. SCIENTIFIC AND TECHNICAL PROGRESS IS MONITORED THROUGH SEMI-ANNUAL AND ANNUAL REPORTS FROM THE GRANTEES AS WELL AS THROUGH DIRECT CONTACT WITH INVESTIGATORS BOTH BY TELECONFERENCE AND SITE VISITS, AND FOLLOW UP TO PROGRESS REPORTS AND SITE VISITS WHERE SCIENTIFIC QUESTIONS OR ADMINISTRATIVE ISSUES ARE IDENTIFIED. SCIENTIFIC REPORT SUBMISSIONS COVER A WIDE RANGE OF ITEMS INCLUDING INDIVIDUAL OBJECTIVES AND OVERALL PROGRESS REVIEW, MILESTONE ACHIEVEMENT, PROJECT PLAN UPDATE, AND ANY OTHER SIGNIFICANT CHANGES. FINANCIAL REPORTING IS REQUIRED ANNUALLY FOR ALL OF THE GRANTEES, AND SEMI-ANNUALLY FOR INSTITUTIONS THAT REQUIRE ADDITIONAL OVERSIGHT, SUCH AS FOR-PROFIT INSTITUTIONS. DUE DILIGENCE PROCEDURES, SUCH AS FNIH COMPLIANCE WITH THE USA PATRIOT ACT AND IRS REQUIREMENTS ON EXPENDITURE RESPONSIBILITIES, HAVE BEEN INCORPORATED INTO THE REPORTING PROCESS TO ENSURE THAT THE GRANTEES ARE COMPLYING WITH GRANT, LEGAL, FINANCIAL, AND REGULATORY REQUIREMENTS. FELLOWS SELECTED FOR FOUNDATION FELLOWSHIPS ARE SELECTED THROUGH NATIONWIDE AND INTERNATIONAL COMPETITIONS. THE CLINICAL RESEARCH TRAINING PROGRAM (CRTP) IS OPEN TO ALL THIRD YEAR STUDENTS ENROLLED IN MEDICAL OR DENTAL SCHOOLS. THE WOMEN'S HEALTH FELLOWSHIP PROGRAMS ARE OPEN TO DOCTORAL-LEVEL CANDIDATES WITHIN FIVE YEARS OF RECEIPT OF THE DOCTORAL DEGREE. APPLICATIONS, CONTAINING TRANSCRIPTS AND ESSAYS ON THEIR RESEARCH GOALS ARE SUBMITTED AND REVIEWED BY PANELS OF NIH SCIENTISTS WHO MAKE RECOMMENDATIONS FOR SELECTION. POTENTIAL FELLOWS ARE OFTEN BROUGHT TO THE CAMPUS FOR INTERVIEWS AND FINAL SELECTION. THE FOUNDATION'S FELLOWSHIPS ARE OPEN TO PROFESSIONALS WORKING AT VARIOUS STAGES OF THEIR RESEARCH CAREERS. APPLICANTS TO THE NEUROSCIENCE FELLOWSHIP, FOR EXAMPLE, ARE YOUNG SCIENTISTS WHO WILL BENEFIT FROM EXPERIENCE OF CLINICAL AND BASIC SCIENCE RESEARCH. THE DIRECTOR'S FELLOWSHIP IN COMPLEMENTARY AND ALTERNATIVE MEDICINE RESEARCH SEEKS A MORE EXPERIENCED SCIENTIST WHO IS WELL-POSITIONED TO BECOME A LEADER IN THE FIELD OF COMPLEMENTARY ALTERNATIVE MEDICINE.Explanation

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Independent ConsultantXIndependentConsultant
Written Employment ContractXWrittenEmploymentContract
Compensation SurveyXCompensationSurvey
Board Or Committee ApprovalXBoardOrCommitteeApproval
Severance Payment0SeverancePayment
Supplemental Nonqual Retire Plan0SupplementalNonqualRetirePlan
Equity Based Comp Arrangement0EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org0CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs0CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org0CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs0CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments0AnyNonFixedPayments
Initial Contract Exception0InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (11 entries)

Base Compensation Filing OrgBaseCompensationFilingOrgComp Based On Related OrgsCompBasedOnRelatedOrgsBonus Filing OrgBonusFilingOrgBonus Related OrgsBonusRelatedOrgsOther Compensation Filing OrgOtherCompensationFilingOrgOther Compensation Related OrgsOtherCompensationRelatedOrgsDeferred Comp Filing OrgDeferredCompFilingOrgDeferred Comp Related OrgsDeferredCompRelatedOrgsNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgNontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgsTotal Compensation Filing OrgTotalCompensationFilingOrgTotal Compensation Related OrgsTotalCompensationRelatedOrgsComp Report Prior990 Filing OrgCompReportPrior990FilingOrgComp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
SCOTT CAMPBELL
222288000026825222290459602491132682500
DAVID WHOLLEY
254463000396035802258420996002942253580200
STEPHANIE JAMES
261148000026115261150002872632611500
ANDREA BARUCHIN
18231000020022847182510459602053572284700
RICHARD SCARFO
165114000026471165110996001915852647100
JULIE TUNE
16764300050026774168140996001949172677400
ANN ASHBY
19246600072029279193190996002224652927900
JULIE WOLF-RODDA
171808000027141171810996001989492714100
MICHAEL GOTTLIEB
214468000021447214470002359152144700
JUDITH SIUCIAK
14427000060024447144870996001693172444700
GAIL LEVINE
132905000380023631136710996001603362363100

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (13 entries)

IdentifierIdentifierReturn ReferenceReturnReferenceExplanationExplanation
STATEMENT OF ORGANIZATION'S PRIMARY EXEMPT PURPOSE STATEMENTFORM 990, PART III, LINE 1, DESCRIPTION OF ORGANIZATION MISSION:THE FOUNDATION FOR THE NATIONAL INSTITUTES OF HEALTH WAS ESTABLISHED BY CONGRESS TO SUPPORT THE MISSION OF THE NATIONAL INSTITUTES OF HEALTH: IMPROVING HEALTH THROUGH SCIENTIFIC DISCOVERY. THE FOUNDATION IS A LEADER IN IDENTIFYING AND ADDRESSING COMPLEX SCIENTIFIC AND HEALTH ISSUES. IT IDENTIFIES AND DEVELOPS INNOVATIVE PUBLIC-PRIVATE PARTNERSHIPS WITH INDUSTRY, ACADEMIA, FOUNDATIONS, ASSOCIATIONS, AND INDIVIDUALS FOR BIOMEDICAL RESEARCH, EDUCATION AND TRAINING.
PROGRAM ONE: RESEARCH PARTNERSHIPSFORM 990, PART III, LINE 4A, PROGRAM SERVICE ACCOMPLISHMENTS:FROM FUNDAMENTAL SCIENCE THAT PEERS DEEP INTO THE RECESSES OF CELLS TO CLINICAL TRIALS THAT CONFIRM THE SAFETY AND EFFICACY OF NEW PATIENT THERAPIES, THE FNIH CREATES PARTNERSHIPS THAT ADDRESS THE WORLD'S MOST PRESSING BIOMEDICAL CHALLENGES. FORMING COLLABORATIONS UNIQUELY SUITED TO THE TASK AT HAND, THE FOUNDATION CAN FIND WAYS TO SUPPORT RESEARCH INTO BASIC BIOCHEMICAL PROCESSES AS WELL AS DISEASES OF GLOBAL EPIDEMIC PROPORTION. EMBRACING AN EVER WIDER UNIVERSE OF PARTNERS, THE FNIH IS HELPING THE NIH TO INFORM NOT ONLY MEDICAL SCIENCE, BUT REGULATORY AND POLICY-MAKING AGENCIES THAT DIRECTLY IMPACT HEALTH CARE DELIVERY. KEY INITIATIVES IN GLOBAL HEALTH GRAND CHALLENGES IN GLOBAL HEALTH THE GRAND CHALLENGES IN GLOBAL HEALTH (GCGH) INITIATIVE ENCOURAGES SCIENTISTS FROM AROUND THE WORLD TO ADDRESS AND OVERCOME SOME OF THE OBSTACLES THAT BLOCK PROGRESS AGAINST DISEASES THAT AFFECT POPULATIONS IN THE DEVELOPING WORLD. GCGH REPRESENTS A MAJOR MILESTONE IN THE DEVELOPMENT OF THE FNIH. ESTABLISHED WITH THE BILL & MELINDA GATES FOUNDATION IN 2003, THE PARTNERSHIP NOT ONLY INTRODUCED THE LARGEST GRANT MADE TO DATE TO THE FNIH, BUT IT CHALLENGED THE FNIH TO BROADEN ITS SUPPORT OF PARTNERSHIPS THROUGH FUNCTIONS WELL BEYOND FUNDRAISING. BY 2005, ADDITIONAL PARTNERS INCLUDED THE WELLCOME TRUST AND THE CANADIAN INSTITUTES OF HEALTH RESEARCH. THE FNIH ASSUMED ONGOING RESPONSIBILITY FOR BOTH THE SCIENTIFIC AND FINANCIAL OVERSIGHT OF 20 OF THE ORIGINAL 43 GCGH PROJECTS, OPERATING IN 25 COUNTRIES. FNIH-SUPPORTED INVESTIGATORS WORKED TO: - IMPROVE UPON EXISTING VACCINES SO AS NOT TO REQUIRE REFRIGERATION OR ADMINISTRATION BY NEEDLE; - ADVANCE VACCINE DEVELOPMENT THROUGH DESIGN OF MORE PROTECTIVE ANTIGENS; - DEVELOP BIOLOGIC, GENETIC AND CHEMICAL STRATEGIES TO CONTROL DISEASE TRANSMISSION BY INSECT VECTORS; - DEVELOP DRUGS AND DELIVERY SYSTEMS THAT MINIMIZE THE LIKELIHOOD OF RESISTANCE; AND - CREATE IMMUNOLOGICAL METHODS TO CURE CHRONIC INFECTIONS. VECTOR-BASED CONTROL OF TRANSMISSION: DISCOVERY RESEARCH MOSQUITO-BORNE DISEASES KILL MILLIONS OF PEOPLE EVERY YEAR. DESPITE RECENT GAINS IN ITS CONTROL, MALARIA REMAINS THE BIGGEST KILLER; AT THE SAME TIME THE INCIDENCE OF DENGUE IS INCREASING DRAMATICALLY AROUND THE WORLD. ABSENT EFFECTIVE VACCINES, PREVENTION STRATEGIES HAVE FOCUSED LARGELY ON CONTROLLING MOSQUITO POPULATIONS AND INHIBITING DISEASE TRANSMISSION TO HUMANS. HOWEVER, AS MOSQUITOES DEVELOP RESISTANCE TO INSECTICIDES, EXISTING APPROACHES ARE NOT ENOUGH. FUNDED BY THE BILL & MELINDA GATES FOUNDATION, THE VECTOR-BASED CONTROL OF TRANSMISSION: DISCOVERY RESEARCH (VCTR) INITIATIVE IS MANAGED BY THE FNIH. IT BUILDS ON THE PROMISING GRAND CHALLENGES IN GLOBAL HEALTH RESEARCH INTO DEPLETING AND/OR INCAPACITATING DISEASE-TRANSMITTING MOSQUITOES. IT HAS THREE AREAS OF FOCUS: - COST-EFFECTIVE AND LONG-LASTING BIOLOGICAL CONTROL METHODS - REPELLENTS OR ATTRACTANTS THAT EXPLOIT OR DISRUPT THE MOSQUITO S ODOR RECEPTORS - SAFER, MORE EFFECTIVE, AND LESS EXPENSIVE INSECTICIDES COMPREHENSIVE T CELL VACCINE IMMUNE MONITORING CONSORTIUM AS THE RESEARCH COMMUNITY HAS COME TO RECOGNIZE THAT THE MOST EFFICIENT WAY TO OVERCOME THE DIFFICULT PROBLEM OF CREATING AN AIDS VACCINE IS THROUGH COLLABORATION AND THE SHARING OF INFORMATION, TOOLS AND MATERIALS, THE FNIH HAS PLAYED A KEY ROLE IN FACILITATING PARTNERSHIPS AMONG LEADING HIV/AIDS RESEARCHERS THROUGH SEVERAL COLLABORATIVE PROJECTS. THE BILL & MELINDA GATES ESTABLISHED THE COLLABORATION FOR AIDS VACCINE DISCOVERY (CAVD TO BRING THE "BIG SCIENCE" APPROACH USED TO SEQUENCE THE HUMAN GENOME TO BEAR ON THE SCOURGE OF HIV/AIDS. IN 2005, THE FNIH PARTNERED WITH DR. RICHARD KOUP, CHIEF OF THE IMMUNOLOGY LAB AT THE VACCINE RESEARCH CENTER (VRC) AT THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, TO ESTABLISH THE COMPREHENSIVE T CELL VACCINE IMMUNE MONITORING CONSORTIUM (CTC- VIMC), A COLLABORATION AMONG LEADING HIV T CELL IMMUNOLOGISTS WHO WOULD WORK TO STANDARDIZE CELLULAR IMMUNOLOGICAL METHODS FOR MONITORING HIV VACCINE TRIALS IN HUMANS AND NON-HUMAN PRIMATES. THE INITIAL 5-YEAR PROJECT WAS THE LARGEST OF THE 26 CAVD AWARDS: $33 MILLION TO SUPPORT THE WORK OF 19 INTERNATIONAL INVESTIGATORS IN 14 INSTITUTIONS. THE CTC-VIMC RECEIVED A SUPPLEMENT OF $16.8 MILLION TO 2016 TO CONTINUE ITS SUCCESSFUL SUPPORT OF THE CAVD AS A CENTRAL SERVICE FACILITY. CENTRALIZED ENVELOPE COMPARATIVE IMMUNOGENICITY PHASE 1 TRIAL THE CENTRALIZED ENVELOPE COMPARATIVE IMMUNOGENICITY PHASE 1 TRIAL (CECI) IS ANOTHER COLLABORATION FOR AIDS VACCINE DISCOVERY (CAVD) PROGRAM ADMINISTERED BY THE FNIH. THE PROJECT FOCUSES ON CLINICAL TESTING OF A NOVEL VACCINE DEVELOPED THROUGH THE USE OF COMPUTATIONAL BIOLOGY TO OVERCOME THE VACCINE-DEVELOPMENT CHALLENGES ARISING FROM THE GENETIC DIVERSITY OF THE HIV VIRUS. APPROVED IN NOVEMBER 2009, THIS $6 MILLION PROJECT BRINGS TOGETHER A NEW MIX OF INVESTIGATORS AND INSTITUTIONS, INCLUDING MANY MAJOR STAKEHOLDERS OF THE GLOBAL HIV/ AIDS VACCINE INITIATIVE: THE CAVD, THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), THE NIAID-SUPPORTED CENTER FOR HIV/AIDS VACCINE IMMUNOLOGY (CHAVI), THE HIV VACCINE TESTING NETWORK (HVTN), AS WELL AS THE VACCINE RESEARCH CENTER, EUROVACC AND SANOFI-PASTEUR. DEVELOPMENT OF A SECOND GENERATION BROADLY NEUTRALIZING ANTIBODY PRODUCT TO PREVENT HIV-1 INFECTION STUDY BY LEADING RESEARCHERS, INCLUDING SEVERAL AT THE VACCINE RESEARCH CENTER (VRC) OF "NON- PROGRESSORS" - THOSE RARE INDIVIDUALS INFECTED WITH HIV WHO DO NOT BECOME SICK - HAS POINTED TO THE ROLE OF BROADLY NEUTRALIZING ANTIBODIES IN HALTING DISEASE PROGRESSION TO FULL-BLOWN AIDS. THE DEVELOPMENT OF A SECOND GENERATION BROADLY NEUTRALIZING ANTIBODY PRODUCT TO PREVENT HIV-1 INFECTION IS A FIVE-YEAR, $1.8 MILLION EFFORT TO HARNESS ONE SUCH ANTIBODY TO BETTER UNDERSTAND THIS PHENOMENON AND PRODUCE NEW TOOLS FOR THE FIGHT AGAINST AIDS. ITS AIM IS TO ENHANCE THE POTENCY, EFFICACY AND EVENTUAL CLINICAL UTILITY OF THE VRC01 MONOCLONAL ANTIBODY THROUGH GENETIC MODIFICATION. IDENTIFICATION OF HIGH-QUALITY HITS FOR TUBERCULOSIS THE HIT-TB PROJECT, LAUNCHED IN 2010, IS AN FNIH PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION AND THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, ALONG WITH THE UNIVERSITIES OF CAPE TOWN, CAMBRIDGE AND DUNDEE. NEGOTIATIONS ARE UNDERWAY WITH POTENTIAL ADDITIONAL PHARMACEUTICAL COMPANY PARTNERS. THIS PROJECT SUPPORTS HIGH-THROUGHPUT SCREENING OF WHOLE MYCOBACTERIUM TUBERCULOSIS BACTERIA USING A CHEMICAL LIBRARY OF DIVERSE, HIGH-QUALITY MOLECULES. THE GOAL IS TO IDENTIFY A SERIES OF WELL-CHARACTERIZED SMALL MOLECULES WITH DEFINED, TRACTABLE BACTERIAL TARGETS, WHICH POTENTIALLY COULD BE DEVELOPED INTO DRUGS AGAINST TUBERCULOSIS MALNUTRITION AND ENTERIC DISEASES NETWORK THE MALNUTRITION AND ENTERIC DISEASES NETWORK (MAL-ED) PROJECT, LAUNCHED IN LATE 2008, IS AN FNIH PARTNERSHIP WITH THE BILL & MELINDA GATES FOUNDATION AND IS CO-LED BY THE NIH'S FOGARTY INTERNATIONAL CENTER AND FNIH. MAL-ED SUPPORTS A NUMBER OF U.S. ACADEMIC AND INTERNATIONALLY BASED INSTITUTIONS AND THE U.S. AND THAI MILITARIES TO FORM A NETWORK OF EIGHT FIELD SITES IN THE DEVELOPING WORLD THAT FOCUS ON POPULATIONS WITH HIGH LEVELS OF MALNUTRITION AND ENTERIC INFECTIONS. MAL-ED SEEKS TO IMPROVE UNDERSTANDING OF THE COMPLEX INTERRELATIONSHIP BETWEEN ENTERIC INFECTIONS AND MALNUTRITION AND TO DESCRIBE ITS COMPOUNDING EFFECTS ON GROWTH, ON IMMUNE RESPONSIVENESS TO ORALLY ADMINISTERED VACCINES AND ON COGNITIVE DEVELOPMENT IN YOUNG CHILDREN IN RESOURCE-POOR ENVIRONMENTS. ONE OF THE PROJECT GOALS IS TO IDENTIFY VULNERABLE PERIODS IN EARLY LIFE, AND WITH THIS KNOWLEDGE DESIGN BETTER INTERVENTION STRATEGIES TO LIMIT THE RISK OF MORTALITY AND MORBIDITY IN CHILDREN. APPROXIMATELY 2,000 CHILDREN HAVE BEEN ENROLLED AT BIRTH AND ARE BEING CLOSELY FOLLOWED UNTIL AT LEAST TWO YEARS OF AGE. THE NETWORK IS PART OF A CONSORTIUM OF AFFILIATED GATES FOUNDATION-FUNDED PROJECTS. ALTHOUGH THESE PROJECTS ARE NOT DIRECTLY MANAGED BY THE FNIH, THEY BENEFIT FROM COLLABORATING WITH MAL-ED INVESTIGATORS AND BY HAVING ACCESS TO MAL-ED RESOURCES, DATA AND SAMPLES. THESE COMPANION PROJECTS SEEK TO IDENTIFY GENETIC MARKERS OF SUSCEPTIBILITY TO CHILDHOOD MALNUTRITION, TO ESTABLISH THE ROLE OF THE GUT MICROBIOME IN MALNUTRITION AND SUSCEPTIBILITY TO ENTERIC INFECTION, AND TO IDENTIFY FACTORS INVOLVED IN CHILDREN'S POOR IMMUNE RESPONSIVENESS TO ORAL POLIO AND ROTAVIRUS VACCINES IN THE DEVELOPING WORLD.
OTHER KEY RESEARCH INITIATIVES THE BIOMARKERS CONSORTIUM FIVE YEARS SINCE ITS FORMATION, THE BIOMARKERS CONSORTIUM HAS HAD A MAJOR IMPACT ON ADVANCING BIOMARKERS AS TOOLS FOR IMPROVING MEDICINE, HAVING LAUNCHED 14 PROJECTS WORTH OVER $45 MILLION. CONSORTIUM PROJECTS FOCUS ON CLINICAL APPLICATION AND REGULATORY QUALIFICATION OF BIOMARKERS, WHICH ALLOWS THEIR PRACTICAL APPLICATION IN STREAMLINING THE DEVELOPMENT OF NEW TREATMENTS AND PROVIDING MORE EFFECTIVE PATIENT CARE IN 2011, THE BIOMARKERS CONSORTIUM: - COMPLETED ITS ALZHEIMER'S DISEASE PLASMA PROTEOMICS PROJECT. THIS PROJECT UTILIZED BLOOD SAMPLES FROM THE GROUNDBREAKING ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE TO QUALIFY BIOMARKERS USEFUL IN DIAGNOSING AND MONITORING PATIENTS; - SUBMITTED INTERIM RECOMMENDATIONS TO THE FDA FOR MEASURING CLINICAL OUTCOMES OF TREATMENTS FOR TWO COMMON TYPES OF INFECTION, COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP) AND ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI). IT ALSO APPROVED THE LAUNCH OF THE SECOND PHASE OF THIS PROJECT, WHICH WILL SEEK TO DEVELOP NEW TOOLS TO MEASURE THESE OUTCOMES FOR USE IN CLINICAL TRIALS; - INITIATED QUALIFICATION WITH THE FDA OF FDG- PET AND VOLUMETRIC CT IMAGING AS MARKERS FOR DISEASE PROGRESSION AND RESPONSE TO THERAPY IN NON-HODGKIN'S LYMPHOMA AND NON-SMALL CELL LUNG CANCER. THIS EFFORT IS MAKING USE OF DATA FROM TWO, FIVE-YEAR CLINICAL STUDIES MANAGED BY THE NATIONAL CANCER INSTITUTE AND FUNDED THROUGH THE CONSORTIUM; - LAUNCHED THE BETA CELL MASS AND FUNCTION PROJECT, WHICH IS AN EFFORT TO STANDARDIZE METHODS THAT MEASURE PANCREATIC BETA CELL FUNCTION AND OPEN THE DOOR TO THE DEVELOPMENT OF NEW TREATMENTS FOR DIABETES. THE ABILITY TO TRACK THE PERFORMANCE OF THESE INSULIN-PRODUCING CELLS SHOULD ALLOW FOR BETTER DETECTION AND MONITORING OF THE PROGRESSION OF DIABETES; AND - LAUNCHED THE KIDNEY SAFETY BIOMARKERS PROJECT, A MAJOR COLLABORATION WITH THE CRITICAL PATH INSTITUTE TO QUALIFY NEW URINARY BIOMARKERS OF ACUTE DRUG-INDUCED KIDNEY INJURY, ENABLING MORE EFFICIENT DEVELOPMENT OF SAFER DRUGS FOR A BROAD RANGE OF DISEASES. OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP'S (OMOP) MISSION IS TO INFORM THE IMPLEMENTATION OF A SYSTEMATIC MEDICAL PRODUCT SURVEILLANCE SYSTEM WITH EMPIRICAL EVIDENCE OF THE APPROPRIATE METHODS, DATA AND INFRASTRUCTURE NECESSARY TO IDENTIFY AND TRACK POTENTIAL RELEVANT SAFETY ISSUES. OMOP IS ONE OF THE MOST AMBITIOUS INITIATIVES IN THE FIELD, WHOSE RESEARCH AGENDA IS ADDRESSING DATA, METHODS, INFRASTRUCTURE AND GOVERNANCE QUESTIONS IN AN OPEN, SCIENTIFIC COLLABORATION. NOW ENTERING ITS FOURTH YEAR OF OPERATIONS, THE EFFORT CONTINUES TO BUILD UPON ITS EXISTING RESEARCH BASE BY ADVANCING METHODOLOGICAL RESEARCH, SUSTAINING AND IMPROVING THE ACCESSIBILITY AND FRAMEWORK OF THE OMOP RESEARCH LAB, AND ENHANCING AND EXPANDING OMOP'S TOOLS AND CAPABILITIES. ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE EIGHT YEARS AFTER ITS INITIAL LAUNCH, THE ALZHEIMER'S DISEASE NEUROIMAGING INITIATIVE (ADNI) HAS PRODUCED NUMEROUS ADJUNCT AND FOLLOW-UP STUDIES THAT ARE NOT ONLY ADVANCING UNDERSTANDING OF THIS DEVASTATING DISEASE, BUT CHANGING THE WAY SCIENTIFIC RESEARCH IS CONDUCTED WORLDWIDE. THE PROGRAM WAS CONCEIVED BY THE NATIONAL INSTITUTE ON AGING WHICH PROVIDES THE PUBLIC SUPPORT, AND THE FNIH PROVIDING SUPPORT FROM THE PRIVATE PARTNERS, WITH THE GOAL OF ENCOURAGING COLLABORATION BY A WIDE ARRAY OF RESEARCHERS IN ACADEMIA AND INDUSTRY. TO DO THAT, THE INITIATIVE HAD TO FIRST SOLVE THE PROBLEM OF STANDARDIZING COLLECTION OF DIFFERENT TYPES OF RESEARCH DATA. IT ESTABLISHED DETAILED PROTOCOLS FOR ENROLLING PATIENTS IN THE STUDY AND FOR COLLECTING AND ASSESSING THE CLINICAL/NEUROPSYCHOLOGICAL, NEUROIMAGING, AND OTHER BIOMARKER TESTS AND MEASURES USED TO TRACK DISEASE PROGRESSION OVER TIME. NEXT, IT CREATED AN OPEN DATABASE, WHERE DATA COULD BE UPLOADED AND DOWNLOADED AS THEY WERE GENERATED. THIS ENABLED RESEARCHERS AROUND THE WORLD TO ACCESS, SHARE AND COMPARE DATA AND FINDINGS QUICKLY, EVEN BEFORE PUBLICATION OF PAPERS. THE NET EFFECT IS A SIGNIFICANT ACCELERATION OF CRITICAL, AND OTHERWISE EXPENSIVE, RESEARCH. SUBPOPULATIONS AND INTERMEDIATE OUTCOME MEASURES IN COPD STUDY WHILE THE INCIDENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IS INCREASING SHARPLY IN THE U.S., A CURE REMAINS OUT OF REACH FOR THIS PROGRESSIVE AND DEBILITATING CONDITION. THE SUBPOPULATIONS AND INTERMEDIATE OUTCOME MEASURES IN COPD STUDY (SPIROMICS) IS LAYING THE GROUNDWORK FOR CLINICAL TRIALS THAT COULD SPEED DEVELOPMENT OF EFFECTIVE THERAPIES. SUPPORTED BY THE FNIH AND SIX PRIVATE SECTOR PARTNERS, NATIONAL HEART, LUNG AND BLOOD INSTITUTE (NHLBI) IS COLLECTING AND POOLING LUNG FUNCTION, IMAGING AND BIOCHEMICAL DATA FROM MORE THAN 3,000 COPD SUFFERERS AND CONTROLS OVER THREE YEARS. THESE DATA WILL ALLOW SCIENTISTS TO BETTER CATEGORIZE PATIENTS ACCORDING TO THEIR SPECIFIC COPD PROFILE, WHICH IN TURN SHOULD HELP THEM TAILOR POTENTIAL THERAPIES TO THOSE MOST LIKELY TO BENEFIT. RESEARCH PARTNERSHIP IN COGNITIVE AGING SCIENTISTS THROUGHOUT THE COUNTRY MET IN OCTOBER 2011 TO DISCUSS THEIR LATEST FINDINGS ON CHANGES IN BRAIN FUNCTION AND BEHAVIOR ASSOCIATED WITH NORMAL AGING. THE RESEARCHERS ARE GRANT RECIPIENTS FROM THE RESEARCH PARTNERSHIP IN COGNITIVE AGING, AN FNIH INITIATIVE WITH THE NATIONAL INSTITUTE ON AGING AND THE MCKNIGHT BRAIN RESEARCH FOUNDATION. THE PROGRAM AIMS TO EXPAND UNDERSTANDING OF HOW PEOPLE THINK, LEARN AND REMEMBER WITH AGE, AND TO DEVELOP INTERVENTIONS TO MAINTAIN COGNITIVE HEALTH AS THEY GROW OLDER. ALTOGETHER, THE $28 MILLION PARTNERSHIP IS FUNDING 17 DIFFERENT RESEARCH PROJECTS OVER THE COURSE OF FIVE YEARS.
PROGRAM TWO: FELLOWSHIPS AND TRAINING PROGRAMSFORM 990, PART III, LINE 4B, OTHER PROGRAM SERVICES:JUST AS VITAL AS FUNDAMENTAL LABORATORY WORK IN ADVANCING BIOMEDICINE, TRAINING AND EDUCATION PROGRAMS MUST BE ROBUST AND ACCESSIBLE TO EQUIP AND INSPIRE THE NEXT GENERATION OF YOUNG SCIENTISTS. THROUGH ITS SUPPORT OF LECTURES, COURSEWORK, INTERNSHIPS, FELLOWSHIPS, RESIDENCIES AND SCHOLARSHIPS, THE FNIH HELPS TO ENSURE THAT THE PROGRESS OF BIOMEDICAL RESEARCH CONTINUES APACE. THE FNIH FUNDING OFTEN CAN EXPAND SUBSTANTIALLY THE REACH OF TRAINING PROGRAMS BY AFFORDING VIDEOCONFERENCE AND REMOTE-SITE LINKAGES. EXAMPLES INCLUDE: THE BERNARD OSHER FOUNDATION/ NCCAM COMPLEMENTARY AND ALTERNATIVE MEDICINE PRACTITIONER RESEARCH CAREER DEVELOPMENT AWARD IN PARTNERSHIP WITH THE NATIONAL CENTER FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE (NCCAM) AT THE NIH, THE OSHER FOUNDATION PROVIDES SUPPORT FOR NCCAM FELLOWSHIPS TO INDIVIDUALS STUDYING COMPLEMENTARY AND ALTERNATIVE MEDICINE. AWARDEES RECEIVE UP TO FIVE YEARS OF INTENSIVE, SUPERVISED CAREER DEVELOPMENT RESEARCH TRAINING IN BIOMEDICAL, BEHAVIORAL OR CLINICAL SCIENCES RELATED TO COMPLEMENTARY AND ALTERNATIVE MEDICINE. SAYER VISION RESEARCH LECTURE NAPOLEONE FERRARA, M.D., PH.D., A FELLOW AT GENENTECH, INC., DELIVERED THE FIFTH SAYER VISION RESEARCH LECTURE AT THE NIH IN JUNE 2011. FERRARA'S ADDRESS WAS ENTITLED, "BASIC SCIENCE AND CLINICAL APPLICATION OF VEGF." EARLY IN HIS CAREER, FERRARA PLAYED A KEY ROLE IN ISOLATING AND CLONING VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF), A PROTEIN THAT STIMULATES FORMATION OF NEW BLOOD VESSELS. HE IDENTIFIED THE PROTEIN'S ROLE IN ABNORMAL VESSEL GROWTH IN EYE DISEASES SUCH AS WET AGE-RELATED MACULAR DEGENERATION (AMD), A LEADING CAUSE OF VISION LOSS IN OLDER AMERICANS. BUILDING ON THAT RESEARCH, HIS LABORATORY DEVELOPED AN ANTI-VEGF ANTIBODY FRAGMENT, WHICH CAN SIGNIFICANTLY IMPROVE SIGHT IN WET AMD PATIENTS AND LIMIT FURTHER VISION LOSS. THIS WORK EARNED HIM THE 2010 LASKER-DEBAKEY CLINICAL MEDICAL RESEARCH AWARD - ONE OF THE MOST PRESTIGIOUS AWARDS IN SCIENCE. LABORATORY ANIMAL MEDICINE RESIDENT TRAINING PROGRAM THE NIH, THROUGH THE DIVISION OF VETERINARY RESOURCES AND THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE, HAS DEVELOPED THE LABORATORY ANIMAL MEDICINE RESIDENT TRAINING PROGRAM. THIS PROGRAM PREPARES LABORATORY ANIMAL VETERINARIANS AND DEVELOPS A RESOURCE OF SPECIALLY TRAINED LABORATORY ANIMAL VETERINARIANS FOR THE NIH INTRAMURAL RESEARCH PROGRAM AS WELL AS THE ENTIRE LABORATORY ANIMAL AND RESEARCH COMMUNITY.
PROGRAM THREE: CAPITAL PROJECTSFORM 990, PART III, LINE 4C, OTHER PROGRAM SERVICES:THE FOUNDATION'S CAPITAL PROJECTS ENHANCE THE RESEARCH ENVIRONMENT AT NIH, SUPPORTING AND PROMOTING THE IMPORTANT DISCOVERIES THAT RESULT FROM NIH'S LEADING-EDGE WORK. THE EDMOND J. SAFRA FAMILY LODGE, FOR EXAMPLE, OPENED IN 2005 TO SERVE AS A COMFORTABLE HOME-AWAY-FROM-HOME FOR FAMILIES THAT COME TO NIH'S CAMPUS IN BETHESDA, MARYLAND TO ACCOMPANY PATIENTS WHO ARE PARTICIPATING IN CLINICAL TRIALS OR RECEIVING TREATMENT AT NIH'S CLINICAL CENTER. SO FAR, THE LODGE HAS HOSTED MORE THAN 40,000 FAMILY MEMBERS AND CAREGIVERS OF ADULT PATIENTS FROM ALL OVER THE WORLD.
MEMORIALS, AWARDS AND EVENTSFORM 990, PART III, LINE 4C, OTHER PROGRAM SERVICES:THE FNIH OVERSEES A NUMBER OF DONOR ADVISED FUNDS CREATED TO SUPPORT SPECIFIC AREAS OF RESEARCH OR FELLOWSHIPS, LECTURES OR AWARDS AT THE NATIONAL INSTITUTES OF HEALTH. THESE FUNDS INCLUDE: THE GRAMLICH MELANOMA RESEARCH FUND SUPPORTS MELANOMA RESEARCH AT THE NIH THROUGH AN ANNUAL GIFT PROVIDED BY THE JACK GRAMLICH FOUNDATION. THE SAYER VISION RESEARCH FUND SUPPORTS AN ANNUAL LECTURE DELIVERED BY AN INVESTIGATOR IN THE AREA OF VISION RESEARCH, AS WELL AS THE SAYER VISION RESEARCH AWARD, A GRANT-IN-AID TO SUPPORT THE RESEARCH OF A PROMISING INDEPENDENT INVESTIGATOR, IN THE EARLY STAGE OF HIS OR HER RESEARCH CAREER IN THE DIVISION OF INTRAMURAL RESEARCH AT THE NATIONAL EYE INSTITUTE. THE ADAM J. BERRY MEMORIAL FUND WAS ESTABLISHED BY MICHAEL AND SUE BERRY IN MEMORY OF THEIR BELOVED SON, ADAM. ADAM CAME FROM AUSTRALIA TO WORK AS A RESEARCH SCIENTIST AT THE NATIONAL CANCER INSTITUTE. THE FUND COMMEMORATES HIS LIFE AND HIS ENTHUSIASM FOR WORK BY MAKING IT POSSIBLE FOR PROMISING YOUNG AUSTRALIAN SCIENTISTS TO TRAVEL TO THE UNITED STATES AND WORK AT THE NIH. THE DEAN R. O'NEILL RENAL CELL CANCER RESEARCH FUND AND THE DR. EDWARD T. RANCIC MEMORIAL FUND SUPPORT A FELLOWSHIP IN THE LABORATORY OF TUMOR IMMUNOLOGY HEADED BY RICHARD CHILDS, M.D., OF THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE. EVENTS BEYOND THE CONFERENCES AND SYMPOSIA THAT ARE ESSENTIAL TO SCIENTIFIC INFORMATION TRANSFER, EVENTS HAVE COME TO PLAY A VITAL ROLE IN BIOMEDICAL RESEARCH-ATTRACTING NONTRADITIONAL PARTNERS AND FUNDERS TO RESEARCH INITIATIVES AND ENGAGING THE PUBLIC IN DISEASE AND HEALTH AWARENESS. FNIH SUPPORTS A VARIETY OF EVENTS, FROM CAREER FAIRS TO EXHIBITS, RECEPTIONS AND MEDIA OPPORTUNITIES, AS EXEMPLIFIED BY THE FOLLOWING: MHEALTH SUMMIT 2011 INAUGURATED IN 2009, THE SUMMIT WAS CONCEIVED AS A VEHICLE TO CONVERGE TWO COMPLEX AND FAST-CHANGING INDUSTRIES - MEDICAL SCIENCE AND TELECOMMUNICATIONS - TO IMPROVE AND EVEN REVOLUTIONIZE HEALTH CARE DELIVERY WORLDWIDE. THE 2011 SUMMIT INCLUDED KEYNOTE AND OTHER SPECIAL SESSIONS, 14 EDUCATION TRACKS IN THE AREAS OF BUSINESS, POLICY, RESEARCH, TECHNOLOGY, MFINANCE AND END-USER SOLUTIONS. THE HEART TRUTH RED DRESS COLLECTION FASHION SHOW 2011 THE RED DRESS COLLECTION FASHION SHOW AT THE MERCEDES BENZ FASHION WEEK IS A SIGNATURE PART OF THE HEART TRUTH CAMPAIGN, AN INITIATIVE OF THE NATIONAL HEART, LUNG AND BLOOD INSTITUTE OF THE NIH WHICH RAISES AWARENESS OF HEART DISEASE AS THE NUMBER-ONE KILLER OF WOMEN IN AMERICA. SINCE 2008, THE FOUNDATION HAS RAISED FUNDS TO SUPPORT THIS EVENT, AND TO FUND A COMMUNITY ACTION PROGRAM THAT AWARDS GRANTS TO ORGANIZATIONS ACROSS THE COUNTRY PROMOTING WOMEN HEART HEALTH. INTERNATIONAL HUMAN MICROBIOME CONGRESS ATTENTION IS INCREASINGLY BEING FOCUSED ON THE HUMAN MICROBIOME - THE MICROBIAL SPECIES THAT RESIDE ON AND WITHIN THE HUMAN BODY - AS A MEANS TO UNDERSTANDING HEALTH AND DISEASE. THIS MEETING, ORGANIZED BY THE FNIH, ATTRACTED MORE THAN 400 PARTICIPANTS WORLDWIDE. RESEARCHERS FROM THE MEDICAL, MICROBIAL AND COMPUTATIONAL FIELDS CONVENED TO DISCUSS THE COMPLEX RELATIONSHIPS BETWEEN THE MICROBIOME AND THE HUMAN BODY, AND WERE JOINED BY FOOD AND PHARMACEUTICAL INDUSTRY REPRESENTATIVES, SCIENCE REPORTERS AND FUNDERS.
FORM 990, PART VI, SECTION A, LINE 4- CHANGED THE TITLE OF TOP STAFF FROM "EXECTUIVE DIRECTOR" TO "PRESIDENT AND EXECUTIVE DIRECTOR" - INCREASED THE NUMBER OF DIRECTORS FROM 25 TO 27
FORM 990, PART VI, SECTION B, LINE 11PRIOR TO THE SUBMISSION OF THE FOUNDATION FOR NIH'S FORM 990 TO THE INTERNAL REVENUE SERVICE, EACH VOTING MEMBER OF THE BOARD OF DIRECTORS SHALL BE PROVIDED WITH A COPY OF THE FINAL FORM 990 AS COMPLETED BY THE CHIEF FINANCIAL OFFICER. BOARD DIRECTORS SHALL BE PROVIDED WITH AT LEAST TEN BUSINESS DAYS TO REVIEW THE FORM AND RAISE QUESTIONS, MAKE SUGGESTIONS, AND ADDRESS ANY POTENTIAL PROBLEMS OR CONCERNS WITH THE CHIEF FINANCIAL OFFICER. A SPECIAL MEETING OF THE GOVERNANCE COMMITTEE WILL BE CALLED TO REVIEW THE SUGGESTED CHANGES FROM THE BOARD DIRECTORS AND TO APPROVE THE FINAL VERSION OF THE FORM 990 FOR SUBMISSION.
FORM 990, PART VI, SECTION B, LINE 12CTHE FOUNDATION REQUIRES DIRECTORS, OFFICERS, VOLUNTEER COMMITTEE MEMBERS, AND STAFF MEMBERS TO DISCLOSE REAL AND APPARENT CONFLICTS OF INTEREST FOR THEMSELVES AND THEIR FAMILY MEMBERS AND TO ANNUALLY SIGN A STATEMENT OF COMPLIANCE. AFTER A CONFLICT OR AN APPARENT CONFLICT OF INTEREST HAS BEEN DISCLOSED, THE BOARD OF DIRECTORS OR THE BOARD COMMITTEE, OR THEIR DESIGNEE, IN THE ABSENCE OF THE INTERESTED PERSON, SHALL DETERMINE IF THE CONFLICT OF INTEREST OR THE APPEARANCE OF A CONFLICT OF INTEREST EXISTS AND IS MATERIAL AND WILL DECIDE HOW IT IS TO BE MANAGED OR ELIMINATED.
FORM 990, PART VI, SECTION B, LINE 15IN 2008, A CONSULTANT WAS HIRED TO REVIEW, ANALYZE AND DEVELOP A PROCESS OF DETERMINING SALARIES FOR ALL EMPLOYEES OF THE ORGANIZATION. ALL EMPLOYEES WERE INTERVIEWED AND POSITION DESCRIPTIONS DEVELOPED OR AMENDED AS NEEDED. USING MARKET DATA, THE CONSULTANT DEVELOPED PAY BANDS FOR ALL POSITIONS. FINAL RECOMMENDATIONS WERE REVIEWED BY THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR'S COMPENSATION IS REVIEWED AND DETERMINED BY THE EXECUTIVE COMMITTEE OF THE BOARD USING LOCAL MARKET DATA.
FORM 990, PART VI, SECTION C, LINE 19ALL DOCUMENTS ARE AVAILABLE UPON REQUEST. THE AUDITED FINANCIAL STATEMENTS ARE POSTED TO THE ORGANIZATION'S WEBSITE.
CHANGES IN NET ASSETS OR FUND BALANCES:FORM 990, PART XI, LINE 5:NET UNREALIZED LOSSES ON INVESTMENTS: -51,545.
FORM 990, PART XII, LINE 2C:PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.